Scholarlink

<p>Mowat‒Wilson syndrome (MWS), a rare genetic disorder caused by heterozygous loss-of-function mutations in <i>ZEB2</i>, is characterised by significant growth retardation with unclear mechanisms. In this study, we developed a <i>Zeb2</i> haploinsufficient (<i>Zeb2</i><sup>+<i>/−</i></sup>) mouse model that recapitulates key features of MWS, including reduced body weight, impaired intestinal development and skeletal hypoplasia. RNA sequencing revealed significant downregulation of nutrient digestion and absorption pathways in the duodenum of Ze<i>b2</i><sup>+<i>/−</i></sup> mice, which was associated with reduced body fat and bone mass loss. Additionally, Ze<i>b2</i><sup>+<i>/−</i></sup> mice presented severe gut microbiota dysbiosis, as indicated by the depletion of beneficial <i>Actinobacteria</i> and <i>Bifidobacterium</i> and increases in the abundances of the proinflammatory <i>Proteobacteria</i> and <i>Rikenella</i>. These microbial shifts correlated with impaired intestinal development and key growth indicators. Our findings delineate a pathological cascade wherein <i>Zeb2</i> haploinsufficiency disrupts nutrient absorption and bone homeostasis, while concomitant dysbiosis likely exacerbates intestinal dysfunction, collectively driving growth retardation. The model we developed can provide a platform for exploring therapeutic interventions targeting nutritional support and microbiome modulation in MWS.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Impaired nutrient absorption, reduced bone mass and alterations in the gut microbiome contribute to postnatal growth retardation in a mouse model of MWS

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月22日

查看全文
  • Yangyang Ge,
  • Lingya Liu,
  • Lihua Wu,
  • Xiaofan Liu,
  • Yingao Hao,
  • Shixu Wang,
  • Yi Xiong,
  • Zi Yang,
  • Zhen Zhang,
  • Qi Li,
  • Bo Li,
  • Jianxin Wu,
  • Guangxu Ren,
  • Qian Jiang

摘要

Mowat‒Wilson syndrome (MWS), a rare genetic disorder caused by heterozygous loss-of-function mutations in ZEB2, is characterised by significant growth retardation with unclear mechanisms. In this study, we developed a Zeb2 haploinsufficient (Zeb2+/−) mouse model that recapitulates key features of MWS, including reduced body weight, impaired intestinal development and skeletal hypoplasia. RNA sequencing revealed significant downregulation of nutrient digestion and absorption pathways in the duodenum of Zeb2+/− mice, which was associated with reduced body fat and bone mass loss. Additionally, Zeb2+/− mice presented severe gut microbiota dysbiosis, as indicated by the depletion of beneficial Actinobacteria and Bifidobacterium and increases in the abundances of the proinflammatory Proteobacteria and Rikenella. These microbial shifts correlated with impaired intestinal development and key growth indicators. Our findings delineate a pathological cascade wherein Zeb2 haploinsufficiency disrupts nutrient absorption and bone homeostasis, while concomitant dysbiosis likely exacerbates intestinal dysfunction, collectively driving growth retardation. The model we developed can provide a platform for exploring therapeutic interventions targeting nutritional support and microbiome modulation in MWS.